Our Expertise

Single-cell RNA

Single-cell RNA sequencing enables cataloging cells at a scale and resolution unmatched by bulk sequencing.

We analyze single-cell RNA-seq data and integrate datasets across technology platforms, data types (including scATAC-seq), and species.

We perform gene expression analysis, comparisons of pre/post samples and changes, expression heterogeneity.

More About Single Cell Sequencing

Cell free / circulating tumor DNA

Our in-depth cfDNA analysis is suitable for treatment efficacy assessment, clonal evolution and resistance dynamics for biomarker discovery.

Cell-free tumor load helps fill an unmet clinical need for real-time, noninvasive detection of tumor response to targeted therapies prior to radiographic assessment by offering a novel method for analyzing longitudinal changes in ctDNA during systemic treatment.

New opportunities for individualized cancer diagnosis and treatment in various types of tumors are made possible by ctDNA analysis. Minimum Residual Disease (MRD) and disease recurrence are closely related, which allows identify particular genetic and molecular alterations as new MRD detection targets using ctDNA. MRD is regarded as a promising prognostic marker to identify people who may benefit from treatment and are at higher risk of recurrence.

Read More